Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anna Guidetti, Claudia Paba Prada, Jacob P Laubach, Cindy Varga, Michelle E Maglio, Mary McKenney, Deborah Doss, Robert L Schlossman, Constantine Mitsiades, Teru Hideshima, Güllü T Görgün, Irene M Ghobrial, Noopur Raje, Nikhil Munshi, Kenneth C Anderson & Paul G Richardson. (2014)
Pomalidomide for the treatment of relapsed and refractory multiple myeloma. Expert Opinion on Orphan Drugs 2:10, pages 1089-1108.
Read now
Read now
Morie A. Gertz. (2008) New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression. Leukemia & Lymphoma 49:12, pages 2240-2245.
Read now
Read now
Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, Suzanne R Hayman & Shaji K Kumar. (2006) High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma. Expert Review of Anticancer Therapy 6:3, pages 343-360.
Read now
Read now
Articles from other publishers (18)
Gulsah Congur, Ülkuye Dudu Gül & Burcu Ertit Taştan. (2022) Fast, Cheap and Reliable Monitoring of Microalgae-Based Paracetamol Removal from Aquatic Environment Using Electrochemical Sensor Technology. Journal of The Electrochemical Society 169:11, pages 115503.
Crossref
Crossref
Marian Cruz-Burgos, Alberto Losada-Garcia, Carlos D. Cruz-Hernández, Sergio A. Cortés-Ramírez, Ignacio Camacho-Arroyo, Vanessa Gonzalez-Covarrubias, Miguel Morales-Pacheco, Samantha I. Trujillo-Bornios & Mauricio Rodríguez-Dorantes. (2021) New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil. Frontiers in Oncology 11.
Crossref
Crossref
Xiaohong Xia, Yuan Liu, Yuning Liao, Zhiqiang Guo, Chuyi Huang, Fangcheng Zhang, Lili Jiang, Xuejun Wang, Jinbao Liu & Hongbiao Huang. (2019) Synergistic effects of gefitinib and thalidomide treatment on EGFR-TKI-sensitive and -resistant NSCLC. European Journal of Pharmacology 856, pages 172409.
Crossref
Crossref
Ilya D. Ionov, Nicholas P. Gorev, Larissa A. Roslavtseva & David D. Frenkel. (2018) Cetirizine and thalidomide synergistically inhibit mammary tumorigenesis and angiogenesis in 7,12-dimethylbenz(a)anthracene-treated rats. Anti-Cancer Drugs 29:10, pages 956-964.
Crossref
Crossref
Tomomasa Hiramatsu, Jyoji Yoshizawa, Kazuaki Miyaguni, Tetsuro Sugihara, Atsushi Harada, Sayuri Kaji, Goki Uchida, Daisuke Kanamori, Yuji Baba, Shuichi Ashizuka & Takao Ohki. (2018) Thalidomide potentiates etoposide-induced apoptosis in murine neuroblastoma through suppression of NF-κB activation. Pediatric Surgery International 34:4, pages 443-450.
Crossref
Crossref
YEN TA HUANG, CHUAN CHU CHENG, TED H. CHIU & PEI CHUN LAI. (2015) Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer. International Journal of Oncology 47:5, pages 1711-1724.
Crossref
Crossref
Magdy A.H. Zahran, Amira M. Gamal-Eldeen, Enas A. El-Hussieny & Hussein S. Agwa. (2014) Thalidomide dithiocarbamate and dithioate derivatives induce apoptosis through inhibition of histone deacetylases and induction of caspases. Journal of Genetic Engineering and Biotechnology 12:1, pages 65-70.
Crossref
Crossref
Yi-Ping Hung, Ching-Fen Yang & Liang-Tsai Hsiao. (2014) Light Chain Escape Multiple Myeloma Complicated with Catastrophic Extramedullary Plasmacytoma Following Novel Agent Treatment. Journal of Cancer Research and Practice 1:1, pages 39-45.
Crossref
Crossref
Rodrigo Lopes da Silva. (2011) Pancreatic Involvement by Plasma Cell Neoplasms. Journal of Gastrointestinal Cancer 43:2, pages 157-167.
Crossref
Crossref
Rodrigo LOPES DA SILVA. (2012) Extramedullary plasmacytoma of the small intestine: Clinical features, diagnosis and treatment. Journal of Digestive Diseases 13:1, pages 10-18.
Crossref
Crossref
Longjiang Yang, Juan Du, Jian Hou, Hua Jiang & Jianfeng Zou. (2011) Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo. BMC Cancer 11:1.
Crossref
Crossref
Vadim A SoloshonokTakeshi YamadaKazuhiko SakaguchiYasufumi Ohfune. (2009) Concise asymmetric synthesis of configurationally stable 4-trifluoromethyl thalidomide. Future Medicinal Chemistry 1:5, pages 897-908.
Crossref
Crossref
Francesca Magalini, Adriano Stella & Paolo Sansoni. (2008) Completely reversible agranulocytosis in a multiple myeloma patient treated with thalidomide–dexamethasone. Internal and Emergency Medicine 3:4, pages 383-385.
Crossref
Crossref
Matthias Pinter, Martina Wichlas, Katharina Schmid, Christina Plank, Christian Müller, Friedrich Wrba & Markus Peck-Radosavljevic. (2008) Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial. European Journal of Gastroenterology & Hepatology 20:10, pages 1012-1019.
Crossref
Crossref
Ronit Vogt Sionov, Rachel Spokoini, Shlomit Kfir‐Erenfeld, Orly Cohen & Eitan Yefenof. 2008.
127
248
.
K. Munir, M. A. Muneer, A. Tiwari, R. M. Chaudhry & S. Muruganandan. (2007) Effects of Polyether Ionophores on the Protective Immune Responses of Broiler Chickens against Angara Disease and Newcastle Disease Viruses. Veterinary Research Communications 31:7, pages 909-929.
Crossref
Crossref
Chae Hyeong Lee, Yong‐Tark Jeon, Su‐Hyeong Kim & Yong‐Sang Song. (2008) NF‐κB as a potential molecular target for cancer therapy. BioFactors 29:1, pages 19-35.
Crossref
Crossref
Takeshi Yamada, Takuya Okada, Kazuhiko Sakaguchi, Yasufumi Ohfune, Hisanori Ueki & Vadim A. Soloshonok. (2006) Efficient Asymmetric Synthesis of Novel 4-Substituted and Configurationally Stable Analogues of Thalidomide. Organic Letters 8:24, pages 5625-5628.
Crossref
Crossref